Frans van Houten

Frans van Houten is a highly experienced executive with a strong background in healthcare and technology. Currently serving as a member of the Supervisory Board at Affidea and a board member for several companies including Absci, Castor, and Synthesis Health, Frans is actively engaged in advancing integrated healthcare and innovative drug creation. Additionally, Frans holds a position on the Board of Directors at Novartis, contributing to the Science & Technology and Audit Committees. Formerly, Frans was the CEO of Philips, where significant transformations occurred, positioning the company as a leader in health technology. Previous roles include CEO of NXP Semiconductors and various leadership positions at Philips, with a solid educational foundation in economics from Erasmus University Rotterdam.